Conrad F. Mir serves as Executive at CALMARE THERAPEUTICS Inc, where they oversee executive responsibilities. Since joining the company, Conrad F. Mir has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 12, 2018 involved exercising options for 1,000,000 shares valued at $80.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 12, 2018 | CTTC | $80.0K | Option Exercise | 1,000,000 | $0.08 | Discretionary |
Conrad F. Mir currently holds 1,440,751 shares of CALMARE THERAPEUTICS Inc (CTTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Conrad F. Mir has been a net neutral trader of CTTC stock. They have purchased $0 and sold $0 worth of shares.
Conrad F. Mir's most recent insider trade was on Feb 12, 2018, when they sold 1,000,000 shares at $0.08 per share.
Get notified when new Form 4 filings are submitted